Siirry sisältöön
Global sound
pharmaphorum Podcast

pharmaphorum Podcast

Understanding Operation Trialblazer, with Dr Harpreet Singh

· 36 min · Jakso 272

Jakson kuvaus

For a variety of reasons, early stage clinical trials have been moving out of the United States more and more over the past few years, as companies pursue savings and lighter regulatory burden in places like China and Australia. The industry has long urged the US government to take some action to make it more attractive to bring these trials back to the States. That's the broad idea behind Operation TRIALBLAZER, a campaign launched this summer by HHS and the FDA.
On today's podcast, host Jonah Comstock is joined by Dr Harpreet Singh, currently chief medical officer at Precision for Medicine. That's her first private sector job after nearly nine years at the FDA, so she's able to bring both an insider and outsider perspective in discussing this initiative.
In addition to sharing some details about her time at the FDA and how the organisation has changed, Dr Singh discusses the situation in clinical research that's led to the US' leadership in clinical trials slipping away, what's in the Trialblazer plans, and whether she thinks it will be enough to turn the tide.
They also talk a little bit about radiotherapeutics regulation and discuss why having clinical trials in the United States is important not just for the economy, but also for patients who are missing out on opportunities for cutting-edge care.
Tune in for a fascinating primer on a major new US government clinical trials initiative.

Sivusto: pharmaphorum.podbean.com

Livenä, viimeisin tunti: 12 131 kappaletta 6 132 asemalla 146 maassa

Löydä maailma radion kautta

Lisää tapoja löytää (7)

Kuulitko jotain hyvää? Tallenna se tai avaa se suoraan Spotifyssa.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
Bayern 1 OberbayernJatka kuuntelua